Premium Company Profile Antares Pharma

Summary

Introduction

Antares Pharma operates as a specialty drug delivery/pharmaceutical company. It develops, produces, and markets pharmaceutical delivery products based on three drug delivery platforms: transdermal drug delivery platform, fast-melt oral disintegrating tablets platform, and injection device platform.

Scope

• Contains corporate strategy, value chain presence and SWOT Analysis
• Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
• Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Antares Pharma's areas of key therapeutic focus are women's health/urology, central nervous system (cns)/pain and biologics. The company currently markets reusable needle-free injectors, disposable mini-needle injectors, and its vaccine intradermal injectors.

Antares Pharma derives its revenues from the sales of its proprietary reusable needle-free injectors and related disposable products; license fees; milestone payments; and royalties. During 2002-2006, the company's total revenues increased at a CAGR of 2%, from $4 million to $4.3 million.

Antares Pharma is forecasted to record an absolute growth of +$75 million with sales of $4 million in 2006 increasing to $79 million in 2010. The company's major contributor to growth out to 2010 will be royalties, which is expected to contribute +$37 million by 2010, representing 49% of the company's total growth for the period 2006-2010.

Reasons to Purchase

• Access all the important information and analysis on the company in a single report
• Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
• Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Content